Skip to content

Anxiety research published in 2023

Page 11 of 17: studies 201 to 220 of 328, newest first. Back to the anxiety overview

Studies

Using an Online-Based Mindfulness Intervention to Reduce Test Anxiety in Physics Students

Journal of Cognitive Enhancement April 13, 2023 John B. Chancey, Benjamin C. Heddy, Marie Lippmann et al.

Using an 8-week mindfulness intervention, we investigated the mechanisms of mindfulness to address test anxiety in introductory physics II. Our goal was to explore the effectiveness of using an 8-week online mindfulness intervention to address student test anxiety. We used self-report measures to assess participants on mindfulness, emotional regulation, attentional regulation, and physics quiz...

How do mindfulness-based programmes improve anxiety, depression and psychological distress? A systematic review

Current Psychology April 1, 2023 Alan Maddock, Carolyn Blair

Abstract: This study aimed to systematically review studies which conducted a controlled mediation analysis in order to examine the potential mechanisms which underlie mindfulness-based programme’s (MBPs) effects on anxiety, depression and psychological distress in any health or mental health population. Searches of six databases (Medline (Ovid), PsycINFO, Cochrane Central Register of...

The Role of Dispositional Mindfulness in the Impact of Repetitive Negative Thinking on Anxiety and Depression in People with Different Autistic-Like Traits

Mindfulness April 1, 2023 Isa Zappullo, Vincenzo Paolo Senese, Roberta Cecere et al.

Abstract: Objectives: Available data suggest that inflexible allocation of attention in people on the autism spectrum can lead to anxiety and depression symptoms, through the increase of repetitive negative thinking (worry and rumination). In the present study, we used dispositional mindfulness as a proxy to attention flexibility and tested its role in the influence of repetitive negative...

Living With Physical Health Conditions: A Systematic Review of Mindfulness-Based Interventions for Children, Adolescents, and Their Parents.

Journal of pediatric psychology April 1, 2023 Olivia Hughes, Katherine H Shelton, Helen Penny et al.

Objectives: This systematic review aimed to identify and appraise studies investigating the efficacy of mindfulness-based interventions (MBIs) for improving depression, anxiety and parental stress in families affected by childhood physical illnesses, as well as feasibility and acceptability. Methods: Embase, PsycINFO, Scopus, Medline, and PubMed were searched between February 2 and 17, 2021,...

The Effect of Internet-delivered Mindfulness Stress Reduction Combined with Acceptance and Commitment Therapy on Health Anxiety and Quality of Life of Caregiver of Patients Infected by COVID-19: A Randomized Clinical Trial.

April 1, 2023 Shokooh Shahidi, Fatemeh Zargar, Hassan Aghaee Khajelangi et al. 8 citations

Background: Coronavirus disease-19 (COVID-19) is a widespread disease all over the world that has caused many psychological complications such as health anxiety (HA) and low quality of life (QOL). Mindfulness-based approaches could improve these complications. Therefore, this study aimed to investigate the effect of Internet-delivered mindfulness stress reduction combined with acceptance and...

A Comparison of the Anti-Anxiety Effects of Oral Ketamine and Fluvoxamine in Children with Separation Anxiety Disorder Manifesting as School Refusal

Advanced Biomedical Research April 1, 2023 Afsaneh Karbasi Amel, Farzaneh Hosseini 5 citations

Background: Children suffer from a high prevalence of anxiety problems that require prompt treatment. It has been demonstrated that ketamine offers rapid anti-anxiety effects. This study aimed to evaluate ketamine's anti-anxiety impact in the treatment of children with school-refusal separation anxiety disorder. Materials and Methods: In this open-labeled randomized clinical trial, 71 children...

Improvement in Anxiety Symptoms in Depressed Patients Treated With AXS-05 (DEXTROMETHORPHAN-BUPROPION): Results From the Evolve Open-Label, Long-Term Study

CNS Spectrums April 1, 2023 Amanda Jones, Caroline Streicher, Shawn Alter et al.

AbstractBackgroundInnovative therapies to treat individuals with MDD, especially those with comorbid anxiety, are urgently needed.AXS-05 (dextromethorphan HBr 45 mg-bupropion HCl 105 mg) is a novel, oral, investigational NMDA receptor antagonist with multimodal activity. The dextromethorphan component of AXS-05 is an NMDA receptor antagonist and a sigma-1 receptor agonist. The bupropion...

Meditation as a tool to counteract music performance anxiety from the experts’ perspective

Psychology of Music March 29, 2023 Serena Paese, Hauke Egermann 8 citations

Music performance anxiety (MPA) affects numerous musicians, preventing them from performing to the full extent of their abilities. A variety of tools are used to cope with MPA among which is meditation. Although research conducted to date has made a distinction between the types of meditative techniques and their effects, this aspect is still not thoroughly investigated. The aim of this...

Esketamine ameliorates post-stroke anxiety by modulating microglial HDAC3/NF-κB/COX1 inflammatory signaling in ischemic cortex.

European Journal of Pharmacology March 28, 2023 Ailing Huang, Yang Chen, Shaoshuang Wang et al.

Post-stroke anxiety (PSA) is a kind of affective disorder occurring after a stroke, with anxiety as the primary clinical manifestation. PSA's mechanism is unclear, and there are few prevention and treatment measures. Our previous study found that HDAC3 could activate NF-κB signaling through mediated p65 deacetylation, which further influenced microglia activation. That implies HDAC3 may be the...

DOI: 10.1016/j.ejphar.2023.175667 (opens in new tab) Esketamine Microglia Animals Mice, inbred c57bl +6

Speech graph analysis in obsessive-compulsive disorder: The relevance of dream reports.

Journal of Psychiatric Research March 28, 2023 Matilde Gomes, Maria Picó Pérez, Inês Castro et al.

Obsessive-compulsive disorder (OCD) is a distressing disorder characterized by the presence of intrusive thoughts, images or urges (obsessions) and/or behavioral efforts to reduce the anxiety (compulsions). OCD lifetime prevalence varies between 1% and 3% in the general population and there are no reliable markers that support the diagnosis. In order to fill this gap, Computational Psychiatry...

Contribution of serotonin 5-HT2A receptor to antidepressant effect of serotonergic psychedelics

Folia Pharmacologica Japonica March 28, 2023 Daisuke Ibi 1 citation

Major depressive disorder presents a substantial global health burden, and at least 30-40% of patients exhibit treatment resistance to antidepressants. Ketamine, an NMDA receptor antagonist, is used as an anesthetic agent. In 2019, the U.S. Food and Drug Administration (FDA) approved esketamine (the S-enantiomer of ketamine) as a therapeutic agent for treatment-resistant depression; however,...

Effect of mindfulness-based interventions on students with mathematics anxiety: a discursive-analytic review

KONSELOR March 22, 2023 Vera Victor-Aigbodion

Most students are affected by mathematics anxiety in terms of how they study, recall, and comprehend mathematical concepts. Mathematics anxiety significantly impedes students' efforts to attend or study mathematics courses. Researchers have developed mindfulness-based interventions (MBIs) to aid in the recovery of students suffering from academic anxiety, particularly mathematics anxiety. The...

Influence of Mindfulness on Levels of Impulsiveness, Moods and Pre-Competition Anxiety in Athletes of Different Sports.

Healthcare March 21, 2023 Laura C Sánchez-sánchez, Clemente Franco, Alberto Amutio et al. 35 citations

Training in emotional regulation skills is one of the most important resources for the adaptation of athletes to contexts of sports pressure, especially during competitions. This study explored the effects of a mindfulness programme (Flow Meditation) on levels of impulsivity, mood and pre-competition anxiety-state in a sample of athletes (N = 41, 22.83 ± 5.62 years). Participants were randomly...

Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial

Journal of Psychopharmacology March 20, 2023 Jordan Sloshower, Hamideh Safi-Aghdam, Surbhi Pathania et al. 153 citations

Background: Several early phase studies have demonstrated that psilocybin-assisted therapy has rapid-acting and persisting antidepressant effects from just one or two doses. However, methodological limitations (e.g., placebo-control, blinding) limit interpretability of the existing literature. Methods: In an exploratory placebo-controlled, within-subject, fixed-order study, individuals with...

Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal spray

Psychiatry Research March 15, 2023 Ibrahim Turkoz, J. Craig Nelson, Samuel T. Wilkinson et al. 19 citations

This exploratory post hoc analysis of two pooled 4-week, phase 3, double-blind, placebo- and active-controlled studies that compared esketamine nasal spray plus a newly initiated oral antidepressant (ESK+AD; n = 310) with a newly initiated oral AD plus placebo nasal spray (AD+PBO; n = 208) in patients with treatment-resistant depression (TRD) examined baseline patient demographic and...

Mindfulness may be associated with less prosocial engagement among high intelligence individuals.

Scientific Reports March 14, 2023 Qingke Guo, Sisi Li, Jingu Liang et al.

This study examined the role of dispositional mindfulness in the association between intelligence and prosocial behavior. A total of 759 college students (mean age is 22.03; 477 females) participated in exchange for extra credit in psychology course. The results confirmed a positive relationship between intelligence and prosocial behavior as revealed by many studies, with empathy serving as a...

The efficacy of mindfulness-based therapy for anxiety, social skills, and aggressive behaviors in children and young people with Autism Spectrum Disorder: A systematic review

Frontiers in Psychiatry March 13, 2023 Tundi Loftus, Danielle C Mathersul, Michelle Ooi et al.

Introduction The purpose of this systematic review was to examine the efficacy of mindfulness-based interventions for improving anxiety, social skills, and aggressive behaviors in children and young people (CYP) with Autism Spectrum Disorder (ASD); summarize the results across clinic, home, and school contexts; and evaluate the quality of these interventions for clinical practice. Methods A...

The Impact of Psychedelic Drugs on Anxiety and Depression in Advanced Cancer or other Life-threatening Disease

American Journal of Clinical Oncology March 13, 2023 Dakota Sicignano, Kimberly Snow-Caroti, A. V. Hernandez et al.

Objectives: Life-threatening cancer or other diseases can induce anxiety and depressive symptoms. We performed a systematic review with meta-analyses of randomized controlled trials assessing patients with cancer or other life-threatening diseases using validated anxiety and depression scales. Methods: PubMed was searched up to November 15, 2022 and citations were applied to prespecified...

The effectiveness of mindfulness-based stress reduction (MBSR) on anxiety and depression in patients with multiple sclerosis (MS)

Chronic Diseases Journal March 12, 2023 Alisaleh Ebrahimi, Shahrbanoo Ghahari

BACKGROUND: Multiple sclerosis (MS) is a stressful event in life and anxiety and depression are common in these patients. Mindfulness-based stress reduction (MBSR) may help and reduce mood disorders in patients with MS. In this regard, the present study is carried out aiming to evaluate the effect of MBSR on anxiety and depression in women with MS. METHODS: This was a quasi-experimental study...

MDMA, Internal Family Systems therapy, and the Minnesota model in the resolution of C-PTSD-induced alcohol and diazepam addiction—A retrospective case study

March 10, 2023 Mika Turkia 1 citation preprint

In February 2023, Australia became the first country in the world to allow psychiatrists to prescribe 3,4-methylenedioxymethamphetamine (MDMA) for post-traumatic stress disorder (PTSD). This may have left interested clinicians looking for practical examples of the use of MDMA. In the 1950s and 1960s, psychedelics were successfully utilized in the treatment of alcoholism. This case study, the...